2017 annual financial data
Avalo Therapeutics 2017 Net margin
Direct answer
Net margin was 42.68%.
Operating income was 13,889,982 USD and net income was 11,869,823 USD.
Operating cash flow was 12,519,405 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,813,137 USD
- Operating income
- 13,889,982 USD
- Net income
- 11,869,823 USD
- Operating cash flow
- 12,519,405 USD